View Larger Map
Australia's Biota, Nabi to merge, to list on Nasda MarketWatch MELBOURNE -(MarketWatch)- Australian drug development company Biota Holdings Ltd. BTA.AU said Monday it plans to merge with Nabi Biopharmaceuticals NABI to form a combined company to be listed on Nasdaq. Biota said in a statement the move to the US was ... See all stories on this topic » |
Australia's Biota to take over US drug maker Nabi Reuters | MELBOURNE (Reuters) - Australian flu drug maker Biota Holdings (BTA.AX) has agreed to take over US firm Nabi Biopharmaceuticals (NABI.O) to create a $258 million group and move to the United States, where investors value biotech research more highly ... See all stories on this topic » |